Abstract:Clusterin is an enigmatic glycoprotein with a nearly ubiquitous tissue distribution. It plays important roles in various pathophysiological processes, including tissue remodeling, reproduction, lipid transport, complement regulation, and apoptosis. Clusterin appears to have two main isoforms that result from alternative splicing. The secreted and nuclear forms of clusterin have been reported to play different roles in human malignancies. The purpose of this study was to examine clusterin immunoexpression and its clinical significance in a group of Chinese patients with non-small cell lung cancer (NSCLC). Tissue samples from the primary tumors of 121 patients with completely resected NSCLC were obtained. Clusterin protein expression was evaluated by immunohistochemical staining with an antibody against all clusterin isoforms. Staining patterns were observed and graded based on intensity and density and were correlated with clinical and pathological data. Both cytoplasmic and nuclear clusterin immunostaining patterns were observed. Clusterin staining was observed only in the cytoplasm in 70 patients (57.9%), only in the nucleus in 27 patients (22.3%), and in both the cytoplasm and nucleus in 16 patients (13.2%). A significant association was observed between positive cytoplasmic clusterin expression and histologic type as indicated by adenocarcinomas that were more likely to have clusterin staining only in the cytoplasm. Clusterin immunostaining was neither associated with recurrence-free survival (RFS) nor overall survival of patients by univariate or multivariate analysis. For patients undergoing chemotherapy, those with only cytoplasmic clusterin staining had worse survival than other patients. In conclusion, both cytoplasmic and nuclear immunostaining patterns of clusterin were detected in the tumors of patients with NSCLC. Adenocarcinomas were more likely to have only cytoplasmic staining. The immunoexpression of clusterin was not associated with prognosis, and cytoplasm-only immunostaining of clusterin was inversely correlated with chemosensitivity in this group of patients.

Expression and Significance of Clusterin in Prostate Neoplasm

Study on the expression of Clusterin in testis of infertility men

Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer

Expression and Significance of Clusterin , Bcl- 2 and FasL in Prostate Cancer

Differential Expression of Clusterin Throughout the Cell Cycle in Prostate Cancer Cell Line

Clusterin Immuno-Expression and Its Clinical Significance in Patients with Non-Small Cell Lung Cancer.

Clusterin Expression in EJ Cells and Its Antiapoptosis Mechanism

Study of the antiapoptosis mechanism of clusterin in EJ bladder carcinoma cell line

Expressions of Shh and Stathmin in Prostatic Diseases and Their Clinical Significances

Prevention of Cell Death in LNCaP Cells by Overexpression of Clusterin

Cloning of the prostate cancer related genes with mRNA differential display

Clusterin: a New Therapeutic Target for Malignancies

Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment

Overexpression Levels of Cripto-1 Predict Poor Prognosis in Patients with Prostate Cancer Following Radical Prostatectomy

[P53 Expression and Its Clinical Significance in Prostatic Carcinoma].

Short-term neoadjuvant hormone therapy enhanced expression of clusterin in prostate cancer

Study of the Effect of Lipofectine-Induced Antisense Oligonucleotide of Clusterin on Bladder Cancer EJ Cells

The Expression of PETA-3/CD151 in Non-Small Cell Lung Carcinoma and Its Clinical Significance

Advances in Research on the Role of Clusterin in Treatment of Human Malignancies

Expression of Clusterin in Spermatozoa of Idiopathic Asthenozoospermic Men

Clusterin immunoexpression is associated with early stage endometrial carcinomas